Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Famotidine and COVID-19
IRCT20200509047364N2Phase 3Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in coronavirus disease 2019 (COVID-19) comparing Famotidine + standard treatment with Placebo + standard treatment (2 arms). Started Jun 2020; status: completed.
02
Drugs
famotidine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200509047364N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200509047364N2.